CDEK
← All organizations

Kashiv BioSciences, LLC

For profit

Also known as: Kashiv biosciences | Kashiv BioSciences, LLC | KASHIV BIOSCIENCES LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 7, 2022

First marketed drug

Feb 25, 2022

Last known activity

May 31, 2025

Timeline

2020s

  1. Feb 25, 2022

    Filgrastim— Marketing Organization

  2. Feb 25, 2022

    Filgrastim— NDA Secondary Org

Drugs by trial phase (3 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Marketed drugs (1)

Recent trials (9)

Details

Last known activity
May 31, 2025